@ExpPharma

Fortnightly insight for Pharma Professionals, India's foremost Pharma Publication from The Indian Express Group

 Mumbai, India
expresspharma.in/
Joined July 2012
  • Tweets22.3K
  • Following1.5K
  • Followers11.6K
8.5KMedia
Where does Indian pharma go next? This month’s cover story looks beyond the US. Hear from industry leaders as they share their perspectives on new markets, global opportunities and what lies ahead for Indian pharma. Read story: expresspharma.in/beyond-us-n… @Viveka_Roy @LNair23
60
#DigitalIssue of #ExpressPharma October 2026 ~ Beyond US: New Shores, New Bets is out and available online at t.ly/epmag-oct26 Grab your FREE copy of #DigitalMagazine now! @Viveka_Roy @LNair23 @rbhatkal @ashishrampure @Kalsomekals
204
#CotecnaGroup acquires #EnergonLabs, strengthens global pharma testing capabilities - expresspharma.in/cotecna-gro… | #pharma #pharmanews #healthtech #pharmatech

Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities - Express Pharma

The acquisition enhances Cotecna's ability to support both Indian and international  customers with high-quality and regulatory-compliant testing services 

expresspharma.in
227
#GodavariBiorefineries secures US patent for #cancer treatment molecule - expresspharma.in/godavari-bi… | #pharma #pharmanews #healthtech #pharmatech

Godavari Biorefineries secures US patent for cancer treatment molecule - Express Pharma

The patent extends the company’s intellectual property protection in life sciences following grants in India, China and Japan

expresspharma.in
192
#Pharmacovigilance systems for India: What companies need to have in place - expresspharma.in/pharmacovig… | #pharma #pharmanews #healthtech #pharmatech

Pharmacovigilance systems for India: What companies need to have in place - Express Pharma

Dr J Vijay Venkatraman, Managing Director & CEO, Oviya MedSafe examines the evolving pharmacovigilance expectations in India and highlights the systems, processes and accountability companies need to...

expresspharma.in
1
1
206
#MankindPharma to acquire 70% stake in Armed Cell Therapeutics for EUR 48 million - expresspharma.in/mankind-pha… | #pharma #pharmanews #healthtech #pharmatech

Mankind Pharma to acquire 70% stake in Armed Cell Therapeutics for EUR 48 million - Express Pharma

The deal will give Mankind Pharma access to a pipeline of CAR-T therapies for cancer, including programmes targeting non-Hodgkin lymphoma and small cell lung cancer

expresspharma.in
218
Our next phase of growth focuses on deepening #technology adoption - expresspharma.in/our-next-ph… | #pharma #pharmanews #healthtech #pharmatech #MOVINExpress #MOVINHealthcare

Our next phase of growth focuses on deepening technology adoption - Express Pharma

MOVIN Express, through its specialised MOVIN Healthcare vertical is addressing needs with time-critical delivery solutions, validated temperature-controlled packaging and real-time shipment monitor...

expresspharma.in
205
VP inaugurates #KAUMARACON2026, launches digital initiatives at #AIIA - expresspharma.in/vp-inaugura… | #pharma #pharmanews #healthtech #pharmatech

VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA - Express Pharma

Calls for scientific validation of Ayurveda, highlights child health as a national priority

expresspharma.in
242
#Zydus launches Season 3 of ‘Easiest Exam’ campaign to promote #breastcancer awareness - expresspharma.in/zydus-launc… | #pharma #pharmanews #healthtech #pharmatech

Zydus launches Season 3 of ‘Easiest Exam’ campaign to promote breast cancer awareness - Express...

The campaign will also feature oncologists sharing insights on early detection, timely screening and treatment, while highlighting the important role of caregiver

expresspharma.in
228
Zydus Sunshine Lifesciences signs agreement to set up pharma facility in Sri Lanka - expresspharma.in/zydus-sunsh… | #pharma #pharmanews #healthtech #pharmatech

Zydus Sunshine Lifesciences signs agreement to set up pharma facility in Sri Lanka - Express Pharma

The proposed facility in Horana involves a phased investment of over $20 million, with commercial operations expected to begin in 2028

expresspharma.in
227
Indian #pharmaceutical market records 17.1% growth in September: #EquirusSecurities - expresspharma.in/indian-phar… | #pharma #pharmanews #healthtech #pharmatech

Indian pharmaceutical market records 17.1% growth in September: Equirus Securities - Express Pharma

Strongest monthly growth in three years; 2QFY27 growth reaches 14.7 per cent

expresspharma.in
208
#ISCR, #CHAKRA sign MoU to strengthen clinical research capacity in Maharashtra - expresspharma.in/iscr-chakra… | #pharma #pharmanews #healthtech #pharmatech

ISCR, CHAKRA sign MoU to strengthen clinical research capacity in Maharashtra - Express Pharma

The partnership will focus on GCP and ethics training, research governance, quality frameworks and site readiness across CHAKRA’s hub-and-spoke network

expresspharma.in
172
#NIPER Raebareli, #AstraZeneca India partner to expand clinical trial sites across India - expresspharma.in/niper-raeba… | #pharma #pharmanews #healthtech #pharmatech

NIPER Raebareli, AstraZeneca India partner to expand clinical trial sites across India - Express...

The collaboration will assess and support 25 clinical trial sites across emerging research geographies, with training, mentoring and site-readiness measures

expresspharma.in
271
From botox to algorithms: How #AI is redefining #cosmetic medicine - expresspharma.in/from-botox-… | #pharma #pharmanews #healthtech #pharmatech

From botox to algorithms: How AI is redefining cosmetic medicine - Express Pharma

Dr Ashok Patel, Aesthetic Surgeon, Founder and Chief Medical Officer, Brilliance Cosmocare, explains how AI is shaping skin analysis, cosmetic treatment planning, hair restoration and patient...

expresspharma.in
188
#Biocon secures global settlement with #Genentech for Pebrilzo launch - expresspharma.in/biocon-secu… | #pharma #pharmanews #healthtech #pharmatech

Biocon secures global settlement with Genentech for Pebrilzo launch - Express Pharma

The agreement sets licensed launch dates for Biocon’s pertuzumab biosimilar in the EU, UK, US and other markets

expresspharma.in
299
#GodavariBiorefineries secures Mexican patent for antiviral research - expresspharma.in/godavari-bi… | #pharma #pharmanews #healthtech #pharmatech

Godavari Biorefineries secures Mexican patent for antiviral research - Express Pharma

The patent covers compounds that inhibit V-ATPase and their use in the manufacture of medicaments for treating viral infections

expresspharma.in
1
259
#NuSynth to build chemical process innovation platform with new capital - expresspharma.in/nusynth-to-… | #pharma #pharmanews #healthtech #pharmatech

NuSynth to build chemical process innovation platform with new capital - Express Pharma

The company will use the capital to develop its R&D and technology capabilities, proprietary processes, scale-up capabilities and team

expresspharma.in
251
#Dermatology meets aesthetics: Why the boundary between skin health and cosmetic care is changing - expresspharma.in/dermatology… | #pharma #pharmanews #healthtech #pharmatech

Dermatology meets aesthetics: Why the boundary between skin health and cosmetic care is changing -...

The relationship between dermatology and aesthetic medicine is one of the most compelling issues in recent years. Dermatology has always concerned itself with the diagnosis and treatment of skin...

expresspharma.in
236
India’s #biotech growth story is now a #manufacturing story: G Balaji - expresspharma.in/indias-biot… | #pharma #pharmanews #healthtech #pharmatech

India’s biotech growth story is now a manufacturing story: G Balaji - Express Pharma

As production becomes more complex and highly regulated, digitalisation and automation are emerging as critical enablers. G Balaji, SVP, Energy Industries, ABB India in an exclusive interview with...

expresspharma.in
242
India’s #biotech innovation may be hidden in its #biodiversity - expresspharma.in/indias-biot… | #pharma #pharmanews #healthtech #pharmatech

India’s biotech innovation may be hidden in its biodiversity - Express Pharma

Dr Villoo Morawala Patell, founder of Avesthagen and Avestagenome Project International, discusses how India can turn its biodiversity into an innovation story, while taking ownership of the science...

expresspharma.in
221
Load more